Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6342823 | 0.80 | CYP19A1 (0.31) | — | |
| SCHEMBL15831255 | 0.73 | KDM4E (0.33) | L3MBTL1KDM4ENPC1ALDH1A1 | |
| SCHEMBL9717735 | 0.73 | — | — | |
| SCHEMBL14272279 | 0.73 | — | — | |
| SCHEMBL701236 | 0.72 | KDM4E (0.38) | L3MBTL1KDM4ENPC1ALDH1A1MAPT | |
| SCHEMBL5191918 | 0.71 | L3MBTL1 (0.32) | L3MBTL1KDM4E | |
| SCHEMBL3122943 | 0.68 | L3MBTL1 (0.49) | L3MBTL1KDM4ENPC1ALDH1A1MAPT | |
| SCHEMBL5569224 | 0.67 | — | — | |
| SCHEMBL18762442 | 0.67 | — | — | |
| SCHEMBL4612224 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093409-B2 | Method for producing cyclic unsaturated compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-8093409-B2 | Method for producing cyclic unsaturated compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090299009-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090299009-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2009-12-03 | — | — | US | disclosed |
| WO-2008023823-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299009-A1 | METHOD FOR PRODUCING CYCLIC UNSATURATED COMPOUND | FASN, SQLE, ALOX5 | L3MBTL1 4664/4885KDM4E 4774/4885NPC1 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.